IU Simon Cancer Center physicians to ring NYSE Closing Bell Aug. 19
INDIANAPOLIS -- (Aug. 18, 2009) -- Two physician/researchers with the Indiana University Melvin and Bren Simon Cancer Center will help ring the New York Stock Exchange’s Closing Bell Wednesday, Aug. 19, in recognition of the 10th anniversary of a leading foundation for cancer research
Olympic swimmer and testicular cancer survivor Eric Shanteau will ring the bell alongside his oncologist Lawrence Einhorn, M.D., who with George Sledge, M.D., and others will commemorate the ASCO (American Society of Clinical Oncology) Cancer Foundation’s 10th anniversary.
Their appearance at the stock exchange will help the ASCO Cancer Foundation raise awareness of the need for cancer funding to improve cancer prevention and patient care through education and research.
Dr. Sledge is currently president-elect of ASCO. He will serve as ASCO president beginning in June 2010. Dr. Sledge, a nationally recognized pioneer in the development of novel therapies for breast cancer, is the Ballve-Lantero Professor of Oncology and professor of pathology and laboratory medicine at the Indiana University School of Medicine and physician-researcher at the IU Simon Cancer Center.
Dr. Einhorn, who distinguished himself early in his career with his development in 1974 of a chemotherapy regimen for testicular cancer, is a Distinguished Professor and the Lance Armstrong Professor of Medicine at the IU School of Medicine and physician-researcher at the IU Simon Cancer Center.
Dr. Einhorn was president of ASCO from 2000 to 2001.
The NYSE Closing Bell can be seen live at www.nyse.com.
About the ASCO Cancer Foundation
As the philanthropic affiliate of the American Society of Clinical Oncology (ASCO), the ASCO Cancer Foundation funds research and education programs both in the United States and abroad. By harnessing the knowledge of more than 27,000 oncology professionals in the American Society of Clinical Oncology, we help deliver physician-approved information directly to those in need. Through these efforts, we improve the lives of those affected by cancer.